ViiV Healthcare
About ViiV Healthcare
ViiV Healthcare is an independent, global specialist focused on HIV medicines and research. The company is dedicated to developing innovative therapies for people living with HIV/AIDS and emphasizes a comprehensive approach to prevention, treatment, and community engagement. Headquartered in London, United Kingdom, it highlights global partnerships and patient-centered initiatives to reach communities disproportionately affected by HIV. ViiV positions itself as a leading force in ending HIV through research, clinical trials, and advocacy for accessible care.
Recent News
Shionogi Enters $2.5 Billion Agreement to Acquire All Rights to Radicava
FDA Clears Merck's First Once‑Daily Oral HIV Pill
Regulatory Actions for May 19, 2026
Pfizer to Depart GSK's ViiV as Shionogi Doubles Its Stake
ViiV Ownership Shifts as Pfizer Sells Its Stake
More Data Support Investigational Drug Combo for HIV Therapy
Recent Deals
No recent deals for this company.